Isotretinoin as a Possible Environmental Trigger to Autoimmunity in Genetically Susceptible Patients
Introduction. Isotretinoin is commonly used to treat cystic acne. Definitive mechanisms of action for isotretinoin are not known though despite many side effects having been documented. Various case reports have noted autoimmune diseases succeeding isotretinoin treatment. Case Report. A 16-year-old...
Saved in:
Main Authors: | Jocelyn Nugroho, Bahareh Schweiger |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2017/4207656 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autoimmune sensorineural hearing loss/Meniere’s disease possibly triggered by neurocysticercosis: a case report
by: Hamza Arman Lateef, et al.
Published: (2025-01-01) -
Widening access to isotretinoin in primary care: an evaluation of New Zealand national dispensing data for isotretinoin for acne, 2008–2023
by: Bruce Arroll, et al.
Published: (2025-01-01) -
Isotretinoin-Induced Delusional Disorder, Somatic Subtype
by: Katharine V. Jensen, et al.
Published: (2020-01-01) -
Susceptibility Genes in Thyroid Autoimmunity
by: Yoshiyuki Ban, et al.
Published: (2005-01-01) -
Isotretinoin – Induced AGEP: A Case Report
by: Alotaibi HM, et al.
Published: (2025-02-01)